Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Huggins C, Stevens RE Jr, Hodges CV (1941) Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 43(2):209–223. https://doi.org/10.1001/archsurg.1941.01210140043004
2. Bubley GJ, Balk SP (1996) Treatment of androgen-independent prostate cancer. Oncologist 1(1):30–35. https://doi.org/10.1634/theoncologist.1-1-30
3. Tangen CM, Hussain MH, Higano CS, Eisenberger MA, Small EJ, Wilding G et al (2012) Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). J Urol 188(4):1164–1169. https://doi.org/10.1016/j.juro.2012.06.046
4. Labrie F, Dupont A, Belanger A, Cusan L, Lacourciere Y, Monfette G et al (1982) New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen. Clin Invest Med 5(4):267–275
5. (2000) Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials Prostate Cancer Trialists’ Collaborative Group. Lancet. 355(9214):1491–1498 https://doi.org/10.1016/S0140-6736(00)02163-2
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献